Cite
HARVARD Citation
Farrar, G. et al. (n.d.). [P1–395]: AMYPAD: A EUROPEAN PUBLIC‐PRIVATE PARTNERSHIP TO INVESTIGATE THE VALUE OF β‐AMYLOID BRAIN SCANS AS A DIAGNOSTIC AND THERAPEUTIC MARKER FOR ALZHEIMER's DISEASE. Alzheimer's & dementia. p. P420. [Online].